News

Here you will find all the news about our companies. We keep you informed about our latest events, our publications, our partnerships and our progress in terms of R&D…

COVID-19 | Contingency and continuity plan

PhinC Development has set in motion his contingency and continuity plan and implemented a remote-working plan for all employees.

Read more

Junior Clinical Pharmacokineticist

PhinC Development has an opening position for a junior pharmacokineticist in Montreal. The position is opened for both Master’s degree students looking for an internship or recently graduated scientists.

Read more

Development of a new intra-articular module

Development of a PBPK model of a molecule to be able to simulate the exposure in the synovial fluid and plasma following an intra-articular administration in adults.

Read more

FDA event: PBPK best practices

We participated at the FDA workshop about the development of Best Practices in Physiologically Based Pharmacokinetic Modeling to Support Clinical Pharmacology Regulatory Decision-Making.

Read more

PhinC renews sponsorship to GMP annual symposium

PhinC Development is proud to sponsor and participate in the special event organized by the Groupe de Métabolisme et Pharmacocinétique (GMP) that will be held in Paris on 16th to 18th October 2019.

Read more

The success of our PBPK symposium 2019

PhinC Development would like to thank you for being part of this special event dedicated to the PBPK and organised jointly with Club Phase 1.

Read more

EMA gave a positive opinion about Fexinidazole

We celebrated, together with our colleagues from Drugs for Neglected Diseases initiative - DNDi and partners, the positive opinion given by the European Medicines Agency about Fexinidazole, DNDi’s first “new chemical entity”:

Read more
BioQuébec
Montreal International
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
AFPT